Département de microbiologie, infectiologie et immunologie, Université de Montréal, Succ. Centre-ville, Montréal, PQ, Canada.
PLoS Genet. 2018 Sep 17;14(9):e1007668. doi: 10.1371/journal.pgen.1007668. eCollection 2018 Sep.
Type 1A topoisomerases (topos) are the only ubiquitous topos. E. coli has two type 1A topos, topo I (topA) and topo III (topB). Topo I relaxes negative supercoiling in part to inhibit R-loop formation. To grow, topA mutants acquire compensatory mutations, base substitutions in gyrA or gyrB (gyrase) or amplifications of a DNA region including parC and parE (topo IV). topB mutants grow normally and topo III binds tightly to single-stranded DNA. What functions topo I and III share in vivo and how cells lacking these important enzymes can survive is unclear. Previously, a gyrB(Ts) compensatory mutation was used to construct topA topB null mutants. These mutants form very long filaments and accumulate diffuse DNA, phenotypes that appears to be related to replication from R-loops. Here, next generation sequencing and qPCR for marker frequency analysis were used to further define the functions of type 1A topos. The results reveal the presence of a RNase HI-sensitive origin of replication in the terminus (Ter) region of the chromosome that is more active in topA topB cells than in topA and rnhA (RNase HI) null cells. The S9.6 antibodies specific to DNA:RNA hybrids were used in dot-blot experiments to show the accumulation of R-loops in rnhA, topA and topA topB null cells. Moreover topA topB gyrB(Ts) strains, but not a topA gyrB(Ts) strain, were found to carry a parC parE amplification. When a topA gyrB(Ts) mutant carried a plasmid producing topo IV, topB null transductants did not have parC parE amplifications. Altogether, the data indicate that in E. coli type 1A topos are required to inhibit R-loop formation/accumulation mostly to prevent unregulated replication in Ter, and that they are essential to prevent excess negative supercoiling and its detrimental effects on cell growth and survival.
1 型拓扑异构酶(topos)是唯一普遍存在的 topo。大肠杆菌有两种 1 型拓扑异构酶,拓扑异构酶 I(topA)和拓扑异构酶 III(topB)。拓扑异构酶 I 通过部分松弛负超螺旋来抑制 R 环形成。为了生长,topA 突变体获得补偿性突变,gyrA 或 gyrB(拓扑异构酶)中的碱基替换或包括 parC 和 parE(拓扑异构酶 IV)的 DNA 区域的扩增。topB 突变体正常生长,拓扑异构酶 III 与单链 DNA 紧密结合。体内 topo I 和 III 共享哪些功能,以及缺乏这些重要酶的细胞如何存活尚不清楚。以前,使用 gyrB(Ts) 补偿性突变来构建 topA topB 缺失突变体。这些突变体形成非常长的丝,并积累弥散 DNA,这种表型似乎与从 R 环复制有关。在这里,下一代测序和 qPCR 用于标记频率分析,以进一步定义 1 型拓扑异构酶的功能。结果表明,在染色体的末端(Ter)区域存在一个对 RNase HI 敏感的复制起点,该起点在 topA topB 细胞中的活性高于 topA 和 rnhA(RNase HI)缺失细胞。S9.6 抗体是一种特异性针对 DNA:RNA 杂交体的抗体,用于点印迹实验,以显示 rnhA、topA 和 topA topB 缺失细胞中 R 环的积累。此外,发现 topA topB gyrB(Ts) 菌株,而不是 topA gyrB(Ts) 菌株,携带 parC parE 扩增。当 topA gyrB(Ts) 突变体携带产生拓扑异构酶 IV 的质粒时,topB 缺失转导子没有 parC parE 扩增。总之,这些数据表明,在大肠杆菌中,1 型拓扑异构酶需要抑制 R 环的形成/积累,主要是为了防止 Ter 中不受调节的复制,并且它们对于防止过度负超螺旋及其对细胞生长和存活的不利影响是必不可少的。